Integrated Investment Consultants’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Buy	924 +1	+0.1%	+$249	0.05%	236
2025 Q4	$254K	Sell	923 -22	-2%	-$6.02K	0.05%	230
2025 Q3	$248K	Hold	945	–	–	0.04%	283
2025 Q2	$207K	Hold	945	–	–	0.04%	305
2025 Q1	$212K	Sell	945 -2	-0.2%	-$551	0.04%	303
2024 Q4	$310K	Hold	947	–	–	0.06%	226
2024 Q3	$284K	Sell	947 -10	-1%	-$3.06K	0.06%	242
2024 Q2	$379K	Hold	957	–	–	0.1%	170
2024 Q1	$379K	Sell	957 -6	-0.6%	-$2.22K	0.1%	170
2023 Q4	$339K	Buy	963 +2	+0.2%	+$708	0.11%	170
2023 Q3	$361K	Sell	961 -16	-2%	-$6.19K	0.13%	138
2023 Q2	$374K	Sell	977 -9	-0.9%	-$3.21K	0.12%	152
2023 Q1	$342K	Buy	986 +11	+1%	+$3.21K	0.11%	171
2022 Q4	$229K	Buy	975 +13	+1%	+$3.08K	0.08%	214
2022 Q3	$237K	Sell	962 -4	-0.4%	-$1.22K	0.09%	185
2022 Q2	$292K	Hold	966	–	–	0.11%	163
2022 Q1	$397K	Sell	966 -26	-3%	-$10.2K	0.11%	171
2021 Q4	$465K	Buy	992 +5	+0.5%	+$2.15K	0.12%	144
2021 Q3	$419K	Buy	987 +13	+1%	+$5.48K	0.12%	154
2021 Q2	$350K	Hold	974	–	–	0.1%	191
2021 Q1	$274K	Hold	974	–	–	0.09%	197
2020 Q4	$276K	Hold	974	–	–	0.11%	185
2020 Q3	$268K	Sell	974 -254	-21%	-$67.2K	0.13%	146
2020 Q2	$279K	Buy	+1,228	New	+$241K	0.13%	115
2018 Q4	–	Sell	-1,916	Closed	-$237K	–	187
2018 Q3	$237K	Buy	+1,916	New	+$215K	0.12%	139
2018 Q2	–	Sell	-1,565	Closed	-$138K	–	712
2018 Q1	$138K	Buy	+1,565	New	+$146K	0.05%	251
2017 Q3	$108K	Buy	1,123 +270	+32%	+$24.4K	0.05%	281
2017 Q2	$81K	Buy	+853	New	+$78.5K	0.04%	331